US · Healthcare

Ideaya Biosciences Inc (IDYA)

Biotechnology

Ideaya Biosciences Inc (IDYA) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for IDYA

P/E ratio

18.00

Ideaya Biosciences Inc (IDYA) — FAQ

What is IDYA's P/E ratio?

The price-to-earnings (P/E) ratio for Ideaya Biosciences Inc (IDYA) is 18.00 (data as of 2026-03-24).

Does Ideaya Biosciences Inc pay a dividend?

Dividend yield is not available in the current snapshot for Ideaya Biosciences Inc (IDYA). Check the MyAverix Finance app for the latest dividend data.

What sector is Ideaya Biosciences Inc in?

Ideaya Biosciences Inc (IDYA) is classified in the Healthcare sector (Biotechnology industry).

What exchange is IDYA listed on?

IDYA is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)